Trial Profile
Effects of Ziprasidone Vs. Placebo During the First Four Weeks of Eight Weeks Sertraline Treatment in Patients With Post-Traumatic Stress Disorder (PTSD)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2013
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 01 Aug 2010 Results published in the Journal of Clinical Psychopharmacology
- 01 Aug 2010 Status changed from recruiting to discontinued.
- 19 Jul 2010 New trial record